BSE filing, NSE: DIAMINESQ. Summary written from the filing by ALFA Finder's alert engine.
Diamines & Chemicals Ltd: key numbers
- Share price
- ₹229.68
- Market cap
- ₹230.9 Cr
- Revenue (annual)
- ₹38.48 Cr
- Net profit (annual)
- ₹-12.78 Cr
- P/E (TTM)
- -28.4×Sector 34.1×
- Promoter holding
- 57.57%+0.07% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Diamines & Chemicals Ltd
All →Diamines & Chemicals Q2 FY27 Results: Net Loss of ₹2.2 Cr, Loss Narrows
Diamines & Chemicals Ltd reported revenue from operations of ₹9.9 Cr (+6.5% YoY) and a net loss of ₹2.2 Cr for Q2 FY27.
- Key figure
- Net loss ₹2.2 Cr
Diamines & Chemicals Board Meeting Date
Diamines and Chemicals Ltd has scheduled a board meeting for October 28, 2026. The meeting will consider the company's unaudited financial results for the September quarter.
Diamines & Chemicals Capacity Expansion
Diamines and Chemicals' subsidiary DACL Fine Chem Limited received regulatory Consent to Establish for a new specialty amines manufacturing plant in Andhra Pradesh.
Diamines & Chemicals Other Announcement
Diamines & Chemicals Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI LODR regulations.
Diamines & Chemicals Management Change
Diamines and Chemicals Ltd announced the transfer of two senior management personnel to its wholly-owned subsidiary effective October 01, 2026.
Diamines & Chemicals Annual General Meeting
Diamines and Chemicals held its 50th Annual General Meeting on September 16, 2026, to adopt financial statements and transact various business items.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date